Evaluating Rwe From Observational Studies In Regulatory Decision-Making: Day 1

Evaluating RWE from Observational Studies in Regulatory Decision-Making: Day 1

Evaluating RWE from Observational Studies in Regulatory Decision-Making: Lessons Learned from Trial

Duke-Margolis Live Stream

Evaluating RWE from Observational Studies in Regulatory Decision-Making: Day 2

Enhancing the Application of Real-World Evidence In Regulatory Decision-Making DAY 1

Leveraging Randomized Clinical Trials to Generate RWE for Regulatory Purposes - Day 1

MDUFA IV: Accessing and Using Real-World and Postmarket Data for Regulatory Decision-Making

U.S. Food and Drug Administration

The Role of Real World Evidence in Regulatory Decision Making

BAA Project to Advance Regulatory Science&Leverage Real World Evidence in Regulatory Decision Making

Putnam Data Sciences

What Does Good Look Like Evaluating Decision Grade RWE Pt1

Health Technology Assessment international - HTAi

Second Annual Duke-Margolis Conference on Real-World Data and Evidence

The Evaluation of Evidence for Regulatory Decision Making

An International Framework for Real-World Evidence Day 1: RWE Pilot Project Results

Friends of Cancer Research

The State of Real-World Evidence Policy

Real World Evidence and Data: From Disease management to Evaluating Drug Safety and Effectiveness

Using Real-World Data for FDA Regulatory Decision-Making

Inside Digital Health

ASA Biopharm Webinar: Statistical Considerations for Evaluation of Fit-for-Purpose Real-World Data

ASA Biopharmaceutical Section

The Role of Real-World Evidence in Regulatory and Value-Based Payment Decision-Making

Bipartisan Policy Center

Framework for FDA’s Real-World Evidence Program – Mar 15, 2019

U.S. Food and Drug Administration

A data quality assessment framework for secondary use of observational data from information systems